Clindamycin Phosphate
- Product NDC
- 72611-639
- 11-digit product format
- 726110639
- Labeler code
- 72611
- Product ID
- 72611-639_4ffd5cec-03a6-4531-b8d5-b6e262ee4e3a
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- clindamycin phosphate
- Dosage form
- INJECTION, SOLUTION
- Route
- INTRAVENOUS
- Labeler
- ALMAJECT, INC.
- Application
- NDA050441
- Marketing category
- NDA
- Marketing start
- 1972-10-02
- Marketing end
- 0000-00-00
- Substance
- CLINDAMYCIN PHOSPHATE
- Active strength
- 150 mg/mL
- Pharmacologic classes
- Decreased Sebaceous Gland Activity [PE], Lincosamide Antibacterial [EPC], Lincosamides [CS], Neuromuscular Blockade [PE]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 72611-639-25 | 72611063925 | 25 VIAL in 1 CARTON (72611-639-25) > 4 mL in 1 VIAL (72611-639-01) | 25 vial | 2019-06-30 | 0000-00-00 | No | No | Current |